Fundraising Fox

Rythera Therapeutics

Deerfield Beach, US · Founded 2020 · Delaware corporation

Biotech

Founders & leadership

RB
Rhonda BhagwandeenNamed on SEC filing
DB
Dan BrowneNamed on SEC filing
SH
Stephen HoffmanNamed on SEC filing
RH
Reginald HardyNamed on SEC filing
MG
Marc GraboyesNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.3M disclosed across 1 round · 2022

▶$1.3MraisedMar 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rhonda BhagwandeenExecutive Officer
  • Dan BrowneExecutive Officer, Director
  • Stephen HoffmanDirector
  • Reginald HardyExecutive Officer, Director
  • Marc GraboyesExecutive Officer, Director
Offering amount
$3M
Amount sold
$1.3M
Minimum investment
$25K
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Rythera Therapeutics raised?
Rythera Therapeutics has disclosed $1.3M raised across 1 round.
Where is Rythera Therapeutics headquartered?
Rythera Therapeutics is headquartered in Deerfield Beach, US.